Marilyn F Dille

Summary

Country: USA

Publications

  1. doi request reprint OtoID: new extended frequency, portable audiometer for ototoxicity monitoring
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research NCRAR, 3710 SW US Veterans Hospital Rd, Portland, OR 97239
    J Rehabil Res Dev 50:997-1006. 2013
  2. ncbi request reprint Development and validation of a cisplatin dose-ototoxicity model
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research, Veterans Affairs Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 23:510-21. 2012
  3. doi request reprint Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 21:409-17. 2010
  4. doi request reprint Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model
    Marilyn F Dille
    National Center for Rehabilitative Auditory Research, VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA
    J Acoust Soc Am 128:1163-74. 2010
  5. doi request reprint ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring
    Marilyn F Dille
    Department of Veterans Affairs Rehabilitative Research and Development VA RR and D, National Center for Rehabilitative Auditory Research, Veterans Affairs Medical Center, Portland, OR Oregon Health and Science University, Department of Otolaryngology Head and Neck Surgery, Portland, OR
    J Am Acad Audiol 24:769-81. 2013
  6. doi request reprint The statistical basis for serial monitoring in audiology
    Garnett P McMillan
    Veterans Affairs Rehabilitation Research and Development Service VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR, USA
    Ear Hear 34:610-8. 2013
  7. doi request reprint Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes
    Garnett P McMillan
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, Oregon 97239, USA
    Int J Audiol 51:689-96. 2012
  8. doi request reprint Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring
    Dawn Konrad-Martin
    VA RR and D National Center for Rehabilitative Auditory Research NCRAR, Portland VA Medical Center, Portland, Oregon 97239, USA
    Int J Audiol 51:S51-62. 2012
  9. doi request reprint Age-related changes in the auditory brainstem response
    Dawn Konrad-Martin
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 23:18-35; quiz 74-5. 2012
  10. pmc Meta-Analysis of Distortion Product Otoacoustic Emission Retest Variability for Serial Monitoring of Cochlear Function in Adults
    Kelly M Reavis
    1VA RR and D National Center for Rehabilitative Auditory Research NCRAR, VA Medical Center, Portland, Oregon, USA and 2Department of Otolaryngology HNS, Oregon Health and Science University, Portland, Oregon, USA
    Ear Hear 36:e251-60. 2015

Detail Information

Publications11

  1. doi request reprint OtoID: new extended frequency, portable audiometer for ototoxicity monitoring
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research NCRAR, 3710 SW US Veterans Hospital Rd, Portland, OR 97239
    J Rehabil Res Dev 50:997-1006. 2013
    ..Repeatable hearing threshold results were obtained on all subjects who performed the test, regardless of hearing status or testing location. ..
  2. ncbi request reprint Development and validation of a cisplatin dose-ototoxicity model
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research, Veterans Affairs Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 23:510-21. 2012
    ..A tool to help forecast susceptibility to ototoxic-induced changes in the SRO in advance of each chemotherapy treatment visit may prove useful for ototoxicity monitoring efforts, patient counseling, and therapeutic planning...
  3. doi request reprint Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study
    Marilyn F Dille
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 21:409-17. 2010
    ..is the prevalence and incidence of tinnitus among patients treated with cisplatin, carboplatin, or ototoxic antibiotic therapies? (2) Do commonly reported treatment or subject factors confound or modify the incidence of tinnitus onset?..
  4. doi request reprint Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model
    Marilyn F Dille
    National Center for Rehabilitative Auditory Research, VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA
    J Acoust Soc Am 128:1163-74. 2010
    ..This approach appears to provide an accurate and rapid ototoxicity risk assessment (ORA) that once validated can be used clinically...
  5. doi request reprint ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring
    Marilyn F Dille
    Department of Veterans Affairs Rehabilitative Research and Development VA RR and D, National Center for Rehabilitative Auditory Research, Veterans Affairs Medical Center, Portland, OR Oregon Health and Science University, Department of Otolaryngology Head and Neck Surgery, Portland, OR
    J Am Acad Audiol 24:769-81. 2013
    ..The clinical accuracy of this new method has yet to be determined on a clinical population...
  6. doi request reprint The statistical basis for serial monitoring in audiology
    Garnett P McMillan
    Veterans Affairs Rehabilitation Research and Development Service VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR, USA
    Ear Hear 34:610-8. 2013
    ..An approach that adjusts for this important effect is also described...
  7. doi request reprint Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes
    Garnett P McMillan
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, Oregon 97239, USA
    Int J Audiol 51:689-96. 2012
    ..The goal of the current study was to contrast the diagnostic accuracy of ototoxicity monitoring protocols based on changes in DPOAE levels at wider, more rapidly tested, primary frequency step sizes...
  8. doi request reprint Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring
    Dawn Konrad-Martin
    VA RR and D National Center for Rehabilitative Auditory Research NCRAR, Portland VA Medical Center, Portland, Oregon 97239, USA
    Int J Audiol 51:S51-62. 2012
    ..This prediction must be empirically assessed in noise-exposed subjects...
  9. doi request reprint Age-related changes in the auditory brainstem response
    Dawn Konrad-Martin
    VA RR and D National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, OR 97239, USA
    J Am Acad Audiol 23:18-35; quiz 74-5. 2012
    ..Inferences regarding effects of aging on ABR measures at each rate were derived from the fitted model. Results were compared to data from subjects with poorer hearing...
  10. pmc Meta-Analysis of Distortion Product Otoacoustic Emission Retest Variability for Serial Monitoring of Cochlear Function in Adults
    Kelly M Reavis
    1VA RR and D National Center for Rehabilitative Auditory Research NCRAR, VA Medical Center, Portland, Oregon, USA and 2Department of Otolaryngology HNS, Oregon Health and Science University, Portland, Oregon, USA
    Ear Hear 36:e251-60. 2015
    ....
  11. pmc Hearing Impairment in Relation to Severity of Diabetes in a Veteran Cohort
    Dawn Konrad-Martin
    1United States Department of Veterans Affairs VA, Office of Rehabilitation Research and Development RR and D Services, National Center for Rehabilitative Auditory Research, Portland, Oregon, USA 2Department of Otolaryngology HNS, Oregon Health and Science University, Portland, Oregon, USA 3Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, Oregon, USA 4Department of Audiology, Speech Language Pathology, and Deaf Studies, Towson University, Towson, Maryland, USA
    Ear Hear 36:381-94. 2015
    ....